48 results
8-K
EX-1.1
STOK
Stoke Therapeutics Inc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation
8-K
EX-4.1
STOK
Stoke Therapeutics Inc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
, any other entity and a government or any department or agency thereof.
(g) “Principal Trading Market” means the national securities exchange
424B5
STOK
Stoke Therapeutics Inc
28 Mar 24
Prospectus supplement for primary offering
5:15pm
to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things
424B5
STOK
Stoke Therapeutics Inc
26 Mar 24
Prospectus supplement for primary offering
4:47pm
institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury
PRE 14A
jyowm4 hiw9vl03
17 Apr 23
Preliminary proxy
4:01pm
S-8
EX-99.1
1qtwojd26j9 yv5a6
13 Apr 23
Registration of securities for employees
4:02pm